At a special meeting on Tuesday, June 5, ISTA Pharmaceuticals stockholders voted to approve the merger of ISTA and Bausch & Lomb.

The affirmative vote of the holders of a majority of the outstanding shares of ISTA's common stock was required to approve the proposal to adopt the merger agreement. According to the final tally of shares voted, 78.5% of the outstanding shares of ISTA's common stock as of the close of business on April 23, 2012, the record date, were voted to approve the proposal to adopt the merger agreement. A quorum of 79.32% of ISTA's total outstanding shares of common stock as of the April 23, 2012 record date voted at the special meeting.

The merger, initially announced on March 26, 2012, is expected to close on June 6, 2012.